Pharmaceutical Industry News
The Motley Fool has a nice article examining the current state of the pharmaceutical industry, and even has something nice to say about Pfizer. This bodes well for my investment club, especially considering all the heat everyone is taking over these Cox-2 inhibitors (Vioxx, Bextra, Celebrex).Speaking of those, it looks like Vioxx may be making a comeback. FDA to the rescue!!!
